CoCites: A citation-based method for searching scientific literature

Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.

Victoria E Clark, E Zeynep Erson-Omay, Akdes Serin, Jun Yin, Justin Cotney, Koray Ozduman, Timuçin Avşar, Jie Li, Phillip B Murray, Octavian Henegariu, Saliha Yilmaz, Jennifer Moliterno Günel, Geneive Carrión-Grant, Baran Yilmaz, Conor Grady, Bahattin Tanrikulu, Mehmet Bakircioğlu, Hande Kaymakçalan, Ahmet Okay Caglayan, Leman Sencar, Emre Ceyhun, A Fatih Atik, Yaşar Bayri, Hanwen Bai, Luis E Kolb, Ryan M Hebert, S Bulent Omay, Ketu Mishra-Gorur, Murim Choi, John D Overton, Eric C Holland, Shrikant Mane, Matthew W State, Kaya Bilgüvar, Joachim M Baehring, Philip H Gutin, Joseph M Piepmeier, Alexander Vortmeyer, Cameron W Brennan, M Necmettin Pamir, Türker Kiliç, Richard P Lifton, James P Noonan, Katsuhito Yasuno, Murat Günel. Science 2013
Times Cited: 486

Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas.

Victoria E Clark, Akdes Serin Harmancı, Hanwen Bai, Mark W Youngblood, Tong Ihn Lee, Jacob F Baranoski, A Gulhan Ercan-Sencicek, Brian J Abraham, Abraham S Weintraub, Denes Hnisz, Matthias Simon, Boris Krischek, E Zeynep Erson-Omay, Octavian Henegariu, Geneive Carrión-Grant, Ketu Mishra-Gorur, Daniel Durán, Johanna E Goldmann, Johannes Schramm, Roland Goldbrunner, Joseph M Piepmeier, Alexander O Vortmeyer, Jennifer Moliterno Günel, Kaya Bilgüvar, Katsuhito Yasuno, Richard A Young, Murat Günel. Nat Genet 2016
Times Cited: 171

List of shared articles

Times cited

A molecularly integrated grade for meningioma.
Joseph Driver, Samantha E Hoffman, Sherwin Tavakol, Eleanor Woodward, Eduardo A Maury, Varun Bhave, Noah F Greenwald, Farshad Nassiri, Kenneth Aldape, Gelareh Zadeh,[...]. Neuro Oncol 2022

Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
Simon Gritsch, Tracy T Batchelor, L Nicolas Gonzalez Castro. Cancer 2022

Consensus core clinical data elements for meningiomas (v2021.1).
Farshad Nassiri, Justin Z Wang, Karolyn Au, Jill Barnholtz-Sloan, Michael D Jenkinson, Kate Drummond, Yueren Zhou, James M Snyder, Priscilla Brastianos, Thomas Santarius,[...]. Neuro Oncol 2022

The integrated multiomic diagnosis of sporadic meningiomas: a review of its clinical implications.
Stephanie M Robert, Shaurey Vetsa, Arushii Nadar, Sagar Vasandani, Mark W Youngblood, Evan Gorelick, Lan Jin, Neelan Marianayagam, E Zeynep Erson-Omay, Murat Günel,[...]. J Neurooncol 2022

Intraventricular Meningiomas: Clinical-Pathological and Genetic Features of a Monocentric Series.
Serena Ammendola, Michele Simbolo, Chiara Ciaparrone, Paola Chiara Rizzo, Maria Caffo, Giampietro Pinna, Francesco Sala, Aldo Scarpa, Valeria Barresi. Curr Oncol 2022

Multiple approaches converge on three biological subtypes of meningioma and extract new insights from published studies.
James C Bayley, Caroline C Hadley, Arif O Harmanci, Akdes S Harmanci, Tiemo J Klisch, Akash J Patel. Sci Adv 2022

A new amplicon-based gene panel for next generation sequencing characterization of meningiomas.
Christian Mawrin, Ralf Koch, Natalie Waldt, I Erol Sandalcioglu, Werner E K Braunsdorf, Jan-Peter Warnke, Felix Goehre, Hans-Jürgen Meisel, Christian Ewald, Sina Neyazii,[...]. Brain Pathol 2022

Prognostic impact of genetic alterations and methylation classes in meningioma.
Anna S Berghoff, Thomas Hielscher, Gerda Ricken, Julia Furtner, Daniel Schrimpf, Georg Widhalm, Ursula Rajky, Christine Marosi, Johannes A Hainfellner, Andreas von Deimling,[...]. Brain Pathol 2022

Identification and Management of Aggressive Meningiomas.
Bhuvic Patel, Rupen Desai, Sangami Pugazenthi, Omar H Butt, Jiayi Huang, Albert H Kim. Front Oncol 2022

Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities.
Abrar Choudhury, Stephen T Magill, Charlotte D Eaton, Briana C Prager, William C Chen, Martha A Cady, Kyounghee Seo, Calixto-Hope G Lucas, Tim J Casey-Clyde, Harish N Vasudevan,[...]. Nat Genet 2022

Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand?
Alessia Pellerino, Francesco Bruno, Rosa Palmiero, Edoardo Pronello, Luca Bertero, Riccardo Soffietti, Roberta Rudà. Cancers (Basel) 2022

Genomic profiling of sporadic multiple meningiomas.
E Zeynep Erson-Omay, Shaurey Vetsa, Sagar Vasandani, Tanyeri Barak, Arushii Nadar, Neelan J Marianayagam, Kanat Yalcin, Danielle Miyagishima, Stephanie Marie Aguilera, Stephanie Robert,[...]. BMC Med Genomics 2022

Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index.
Yu Teranishi, Atsushi Okano, Satoru Miyawaki, Kenta Ohara, Daiichiro Ishigami, Hiroki Hongo, Shogo Dofuku, Hirokazu Takami, Jun Mitsui, Masako Ikemura,[...]. Acta Neuropathol Commun 2022

Distinct clinical outcome of microcystic meningioma as a WHO grade 1 meningioma subtype.
Leihao Ren, Lingyang Hua, Zhongyuan Bao, Jiaojiao Deng, Daijun Wang, Jiawei Chen, Hong Chen, Tareq A Juratli, Hiroaki Wakimoto, Ye Gong. J Neurooncol 2022

NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomas.
John W Rutland, Corey M Gill, Joshua Loewenstern, Hanane Arib, Margaret Pain, Melissa Umphlett, Yayoi Kinoshita, Russell B McBride, Joshua Bederson, Michael Donovan,[...]. Cancer Immunol Immunother 2021

Associations of meningioma molecular subgroup and tumor recurrence.
Mark W Youngblood, Danielle F Miyagishima, Lan Jin, Trisha Gupte, Chang Li, Daniel Duran, Julio D Montejo, Amy Zhao, Amar Sheth, Evgeniya Tyrtova,[...]. Neuro Oncol 2021

Meningiomas from a developmental perspective: exploring the crossroads between meningeal embryology and tumorigenesis.
Julien Boetto, Matthieu Peyre, Michel Kalamarides. Acta Neurochir (Wien) 2021

The spatial phenotype of genotypically distinct meningiomas demonstrate potential implications of the embryology of the meninges.
Daniel M Fountain, Miriam J Smith, Claire O'Leary, Omar N Pathmanaban, Federico Roncaroli, Nicoletta Bobola, Andrew T King, Dafydd Gareth Evans. Oncogene 2021

Meningioma: A Pathology Perspective.
Angus Toland, Kristin Huntoon, Sonika M Dahiya. Neurosurgery 2021

TRAF7 mutations and immunohistochemical study of uterine adenomatoid tumor compared with malignant mesothelioma.
Hiroe Itami, Tomomi Fujii, Tokiko Nakai, Maiko Takeda, Yohei Kishi, Fumiaki Taniguchi, Chiyoko Terada, Fumi Okada, Yuji Nitta, Minami Matsuoka,[...]. Hum Pathol 2021

SWI/SNF chromatin remodeling complex alterations in meningioma.
Corey M Gill, Joshua Loewenstern, John W Rutland, Hanane Arib, Margaret Pain, Melissa Umphlett, Yayoi Kinoshita, Russell B McBride, Joshua Bederson, Michael Donovan,[...]. J Cancer Res Clin Oncol 2021

Crispr/Cas-based modeling of NF2 loss in meningioma cells.
Natalie Waldt, Christoph Kesseler, Paula Fala, Peter John, Elmar Kirches, Frank Angenstein, Christian Mawrin. J Neurosci Methods 2021

Associations of pathological diagnosis and genetic abnormalities in meningiomas with the embryological origins of the meninges.
Atsushi Okano, Satoru Miyawaki, Hiroki Hongo, Shogo Dofuku, Yu Teranishi, Jun Mitsui, Michihiro Tanaka, Masahiro Shin, Hirofumi Nakatomi, Nobuhito Saito. Sci Rep 2021

Meningioma: A Review of Epidemiology, Pathology, Diagnosis, Treatment, and Future Directions.
Christian Ogasawara, Brandon D Philbrick, D Cory Adamson. Biomedicines 2021

Commentary: The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma.
Antonio Dono, Ankush Chandra, Leomar Y Ballester, Yoshua Esquenazi. Neurosurgery 2021

Multiple meningiomas arising within the same hemisphere associated with Li-Fraumeni syndrome.
Christopher S Hong, E Zeynep Erson-Omay, Jennifer Moliterno. Surg Neurol Int 2021

Targeting the CSF1/CSF1R axis is a potential treatment strategy for malignant meningiomas.
Jacky Yeung, Vesal Yaghoobi, Danielle Miyagishima, Matthew D Vesely, Tianxiang Zhang, Ti Badri, Ala Nassar, Xue Han, Miguel F Sanmamed, Mark Youngblood,[...]. Neuro Oncol 2021

Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas.
Ilaria Maggio, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Lidia Gatto, Raffaele Lodi, Alba A Brandes. CNS Oncol 2021

GAB1 overexpression identifies hedgehog-activated anterior skull base meningiomas.
Julien Boetto, Julie Lerond, Matthieu Peyre, Suzanne Tran, Pauline Marijon, Michel Kalamarides, Franck Bielle. Neuropathol Appl Neurobiol 2021

Advances in Multidisciplinary Management of Skull Base Meningiomas.
Tamara Ius, Alessandro Tel, Giuseppe Minniti, Teresa Somma, Domenico Solari, Michele Longhi, Pasquale De Bonis, Alba Scerrati, Mario Caccese, Valeria Barresi,[...]. Cancers (Basel) 2021

Biomarkers for differentiating grade II meningiomas from grade I: a systematic review.
Agbolahan A Sofela, Lucy McGavin, Peter C Whitfield, C Oliver Hanemann. Br J Neurosurg 2021

Newly established patient-derived organoid model of intracranial meningioma.
Shintaro Yamazaki, Fumiharu Ohka, Masaki Hirano, Yukihiro Shiraki, Kazuya Motomura, Kuniaki Tanahashi, Takashi Tsujiuchi, Ayako Motomura, Kosuke Aoki, Keiko Shinjo,[...]. Neuro Oncol 2021

Loss-of-Function Mutations in TRAF7 and KLF4 Cooperatively Activate RAS-Like GTPase Signaling and Promote Meningioma Development.
Paul Najm, Peihua Zhao, Mikhail Steklov, Raj Nayan Sewduth, Maria Francesca Baietti, Silvia Pandolfi, Nathan Criem, Benoit Lechat, Teresa Mendes Maia, Delphi Van Haver,[...]. Cancer Res 2021

High-Throughput Mechanistic Screening of Epigenetic Compounds for the Potential Treatment of Meningiomas.
Philip D Tatman, Tadeusz H Wroblewski, Anthony R Fringuello, Samuel R Scherer, William B Foreman, Denise M Damek, Kevin Lillehei, A Samy Youssef, Randy L Jensen, Michael W Graner,[...]. J Clin Med 2021

Type of bony involvement predicts genomic subgroup in sphenoid wing meningiomas.
Lan Jin, Mark W Youngblood, Trisha P Gupte, Shaurey Vetsa, Arushii Nadar, Tanyeri Barak, Kanat Yalcin, Stephanie M Aguilera, Ketu Mishra-Gorur, Nicholas A Blondin,[...]. J Neurooncol 2021

A clinically applicable integrative molecular classification of meningiomas.
Farshad Nassiri, Jeff Liu, Vikas Patil, Yasin Mamatjan, Justin Z Wang, Rupert Hugh-White, Andrew M Macklin, Shahbaz Khan, Olivia Singh, Shirin Karimi,[...]. Nature 2021

Somatic PIK3CA Mutations in Sporadic Cerebral Cavernous Malformations.
Matthieu Peyre, Danielle Miyagishima, Franck Bielle, Françoise Chapon, Michael Sierant, Quitterie Venot, Julie Lerond, Pauline Marijon, Samiya Abi-Jaoude, Tuan Le Van,[...]. N Engl J Med 2021

Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated.
Sybren L N Maas, Damian Stichel, Thomas Hielscher, Philipp Sievers, Anna S Berghoff, Daniel Schrimpf, Martin Sill, Philipp Euskirchen, Christina Blume, Areeba Patel,[...]. J Clin Oncol 2021

Genomic Biomarkers of Meningioma: A Focused Review.
Jacob A Pawloski, Hassan A Fadel, Yi-Wen Huang, Ian Y Lee. Int J Mol Sci 2021

Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets.
Ilaria Maggio, Enrico Franceschi, Vincenzo Di Nunno, Lidia Gatto, Alicia Tosoni, Daniele Angelini, Stefania Bartolini, Raffaele Lodi, Alba Ariela Brandes. Diagnostics (Basel) 2021

Comprehensive overview of extracellular vesicle proteomics in meningioma: future strategy.
Rashmi Rana, Swati Sharma, Nirmal Kumar Ganguly. Mol Biol Rep 2021

TERT Alterations Predict Tumor Progression in De Novo High-Grade Meningiomas Following Adjuvant Radiotherapy.
Jiaojiao Deng, Shuchen Sun, Jiawei Chen, Daijun Wang, Haixia Cheng, Hong Chen, Qing Xie, Lingyang Hua, Ye Gong. Front Oncol 2021

Whole-Exome Sequencing Reveals Recurrent but Heterogeneous Mutational Profiles in Sporadic WHO Grade 1 Meningiomas.
María González-Tablas, Carlos Prieto, Daniel Arandia, María Jara-Acevedo, Álvaro Otero, Daniel Pascual, Laura Ruíz, Iván Álvarez-Twose, Andrés Celestino García-Montero, Alberto Orfao,[...]. Front Oncol 2021